NIFTY 50 22795.9 ▼ (0.51%)
NIFTY NEXT 50 60466.8 ▼ (0.94%)
NIFTY 100 23274.05 ▼ (0.59%)
NIFTY MIDCAP 100 50486.2 ▼ (1.32%)
NIFTY SMALLCAP 100 15636.9 ▼ (0.7%)
NIFTY SMALLCAP 250 14683.4 ▼ (0.57%)
NIFTY MIDCAP SELECT 11198.9 ▼ (1.69%)
NIFTY TOTAL MARKET 11634.25 ▼ (0.67%)
NIFTY BANK 48981.2 ▼ (0.72%)
SENSEX 75311.06 ▼ (0.56%)
BSE BANKEX 55718.18 ▼ (0.82%)

Bajaj Healthcare ‘s Q3 2024-25 Latest News: Profit Grows by 632.73% YoY

[fetch_key]

Highlights

🔹 The presented financial data is Standalone to provide a comprehensive overview of the company performance.
🔹 Sales over the Year and quarter: The company experienced a substantial growth of 13.1 % in the past year, decrease in net sales/revenue by -7.74 %.
🔹 Income over the Year and quarter: There has been either a marginal increase or a decline in other income over the past year which is 197.24 %. Marginal decrease of -9.01% in other income during this quarter.
🔹 Profit over the Year and quarter: Challenges in sustaining profitability for Bajaj Healthcare Limited. Profit dropped by -633.74 % Year to Year, Bajaj Healthcare Limited’s profitability increased by 23.85 % in this quarter.
🔹 EPS over the Year and quarter: EPS declined by -556.25 % Year to Year. EPS increased by 8.63 % in previous quarter. Positive impact on shareholders.

This analytical report on Bajaj Healthcare Limited stretches beyond conventional financial metrics to include an in-depth exploration of the company’s long-term strategic plans and their alignment with current market conditions. It examines the sustainability of the company’s business model in light of emerging market trends and competitive pressures. The insight provided by seasoned industry analysts adds depth to the evaluation, offering predictions that help in assessing the company’s position and potential movements in its stock price. For investors, this report serves as a crucial tool in understanding the intrinsic value of the company and strategizing their investment moves accordingly.

Metrics Previous Year Previous Quarter Current Quarter Quarter to Quarter Difference Year to Year Difference
Sales Rs. 108.573 Cr Rs. 133.089 Cr Rs. 122.794 Cr -7.74 % + 13.1 %
Expenses Rs. 89.03 Cr Rs. 108.56 Cr Rs. 101.15 Cr -6.83 % + 13.61 %
Operating Profit Rs. 19.54 Cr Rs. 24.53 Cr Rs. 21.64 Cr -11.78 % + 10.75 %
OPM % 18 % 18.43 % 17.62 % -0.81 % -0.38 %
Other Income Rs. 0.798 Cr Rs. 2.607 Cr Rs. 2.372 Cr -9.01 % + 197.24 %
Interest Rs. 6.66 Cr Rs. 7.88 Cr Rs. 5.51 Cr -30.08 % -17.27 %
Depreciation Rs. 7.35 Cr Rs. 6.81 Cr Rs. 6.85 Cr + 0.59 % -6.8 %
Profit before tax Rs. 6.33 Cr Rs. 12.45 Cr Rs. 11.65 Cr -6.43 % + 84.04 %
Tax % 12.66 % 32.97 % 28.43 % -4.54 % + 15.77 %
Net Profit Rs. -2.2 Cr Rs. 9.46 Cr Rs. 11.72 Cr + 23.89 % + 632.73 %
EPS in Rs Rs. -0.8 Rs. 3.36 Rs. 3.64 + 8.33 % + 555 %


Today, we’re looking at Bajaj Healthcare Limited’s financial performance for the Q3(Dec 2024-25).Starting with the top line, the company reported a robust year-over-year sales growth of 13.1 %. However, it did see a marginal slip of -7.74 % from the previous quarter. Expenses decreased slightly by -6.83 % quarter-on-quarter, aligning with the annual rise of 13.61 %. Operating profit, while up 10.75 % compared to last year, faced a quarter-on-quarter dip of -11.78 %, signaling a short-term contraction in margins.
The Operating Profit Margin (OPM) % contradicts this narrative, showing weakness on an annual basis with a decrease of -0.38 %, but a shrinkage of -0.81 % sequentially. Other income fell by -9.01 % compared to the last quarter, despite an annual growth of 197.24 %. Interest expenses dropped significantly by -30.08 % from the previous quarter, yet the year-over-year decrease remains at a moderate -17.27 %. Depreciation costs climbed by 0.59 % quarter-on-quarter, yet on an annual scale, they experienced a reduction of -6.8 %. Profit before tax grew annually by 84.04 % but saw a reduction from the preceding quarter by -6.43 %.
Tax expenses as a percentage of profits increased slightly by 15.77 % compared to last year, with a more notable quarter-on-quarter decrease of -4.54 %. Net profit rose by 632.73 % year-on-year but experienced a 23.89 % expansion from the last quarter. And finally, Earnings Per Share (EPS) displayed an annual uptick of 555 % but a quarterly rise of 8.33 %. In summary, Bajaj Healthcare Limited’s annual performance indicates steady growth, although the quarter-on-quarter figures suggest some areas may require strategic attention.

Metrics Previous Year Previous Quarter Current Quarter Quarter to Quarter Difference Year to Year Difference
Sales Rs. 108.573 Cr Rs. 133.089 Cr Rs. 122.794 Cr -7.74 % + 13.1 %
Expenses Rs. 89.03 Cr Rs. 108.56 Cr Rs. 101.15 Cr -6.83 % + 13.61 %
Operating Profit Rs. 19.54 Cr Rs. 24.53 Cr Rs. 21.64 Cr -11.78 % + 10.75 %
Net Profit Rs. -2.2 Cr Rs. 9.46 Cr Rs. 11.72 Cr + 23.89 % + 632.73 %
EPS in Rs Rs. -0.8 Rs. 3.36 Rs. 3.64 + 8.33 % + 555 %


In reviewing Bajaj Healthcare Limited’s 2024-25(Q3) financial snapshot, key trends emerge, shedding light on the company’s performance.Sales saw a robust 13.1 % year-on-year growth, although there was a slight dip of -7.74 % from the previous quarter. Expenses rose by 13.61 % compared to the previous year, with a decrease of -6.83 % quarter-on-quarter. Operating Profit surged by 10.75 % annually, and saw a -11.78 % decrease from the last quarter.
Net Profit showed yearly increase of 632.73 %, and experienced a 23.89 % increase from the previous quarter. Earnings Per Share (EPS) rose by 555 % annually, however rose by 8.33 % compared to the last quarter. In essence, while Bajaj Healthcare Limited exhibits strong annual growth indicators, short-term improvements suggest the potential for recovery and the importance of strategic adjustments to counter market challenges effectively. That’s all for now in the financial sector.

Join our telegram for more updates

Stay Updated with Our YouTube Videos

Related Post